Kunekt Corporation
Kunekt Corporation does not have significant operations. The company intends to acquire or merge with an established business. Previously, it focused on designing, building, and marketing mobile phones, smartphones, and tablets. The company was founded in 2007 and is based in Carson City, Nevada.
Kunekt Corporation (KNKT) - Net Assets
Latest net assets as of July 2012: $-102.67K USD
Based on the latest financial reports, Kunekt Corporation (KNKT) has net assets worth $-102.67K USD as of July 2012.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($105.65K) and total liabilities ($208.32K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-102.67K |
| % of Total Assets | -97.18% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Kunekt Corporation - Net Assets Trend (2008–2011)
This chart illustrates how Kunekt Corporation's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Kunekt Corporation (2008–2011)
The table below shows the annual net assets of Kunekt Corporation from 2008 to 2011.
| Year | Net Assets | Change |
|---|---|---|
| 2011-10-31 | $-14.25K | +93.57% |
| 2010-10-31 | $-221.63K | -124.14% |
| 2009-10-31 | $-98.88K | -226.04% |
| 2008-10-31 | $-30.33K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Kunekt Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1459800.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (October 2011)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $62.00K | % |
| Total Equity | $-14.25K | 100.00% |
Kunekt Corporation Competitors by Market Cap
The table below lists competitors of Kunekt Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
American Leisure Holdings Inc
PINK:AMLH
|
$0.96 |
|
Discovery Minerals
PINK:DSCR
|
$0.96 |
|
Nouveau Life Pharmaceuticals Inc
PINK:NOUV
|
$0.96 |
|
Quick-Med Technologies Inc
PINK:QMDT
|
$0.96 |
|
CVF Technologies Corporation
PINK:CNVT
|
$0.96 |
|
Organic Sales and Marketing Inc
PINK:OGSM
|
$0.96 |
|
Portex Minerals Inc
PINK:STACF
|
$0.96 |
|
Nacel Energy Corp
PINK:NCEN
|
$0.96 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Kunekt Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2010 to 2011, total equity changed from -221,631 to -14,248, a change of 207,383.
- Net income of 231,916 contributed positively to equity growth.
- Share repurchases of 1,750,000 reduced equity.
- Other comprehensive income decreased equity by 24,533.
- Other factors increased equity by 1,750,000.
Equity Change Factors (2010 to 2011)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $231.92K | +1627.71% |
| Share Repurchases | $1.75 Million | -12282.43% |
| Other Comprehensive Income | $-24.53K | -172.19% |
| Other Changes | $1.75 Million | +12282.43% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Kunekt Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2008-10-31 | $0.00 | $0.00 | x |
| 2009-10-31 | $0.00 | $0.00 | x |
| 2010-10-31 | $0.00 | $0.00 | x |
| 2011-10-31 | $0.00 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Kunekt Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (0.00%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | 0.00% | 0.00% | 0.00x | 0.00x | $-49.07K |
| 2009 | 0.00% | 0.00% | 0.00x | 0.00x | $-68.02K |
| 2010 | 0.00% | 0.00% | 0.00x | 0.00x | $-123.05K |
| 2011 | 0.00% | 0.00% | 0.00x | 0.00x | $233.34K |
Industry Comparison
This section compares Kunekt Corporation's net assets metrics with peer companies in the Shell Companies industry.
Industry Context
- Industry: Shell Companies
- Average net assets among peers: $36,677,338
- Average return on equity (ROE) among peers: -64.57%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Kunekt Corporation (KNKT) | $-102.67K | 0.00% | N/A | $0.96 |
| Artius II Acquisition Inc. Class A Ordinary Shares (AACB) | $-60.27K | 0.00% | 0.00x | $198.37 Million |
| Artius II Acquisition Inc. Units (AACBU) | $-60.27K | 0.00% | 0.00x | $205.28 Million |
| Ares Acquisition Corporation II (AACT-UN) | $931.34 Million | 0.00% | 0.08x | $399.77 Million |
| AA Mission Acquisition Corp. (AAM-UN) | $-559.90 Million | 0.00% | 0.00x | $349.76 Million |
| Global Acquisitions Corporation (AASP) | $3.80 Million | -5.26% | 0.34x | $15.42 Million |
| ABV Consulting Inc (ABVN) | $8.75K | -623.31% | 2.50x | $461.96K |
| Atlantic Coastal Acquisition Corp II (ACAB) | $-8.52 Million | 0.00% | 0.00x | $2.44 Million |
| Annabidiol Corp (ACBD) | $-501.57K | 0.00% | 0.00x | $13.62K |
| ACRO Biomedical Co Ltd (ACBM) | $685.87K | -17.12% | 0.46x | $30.04K |
| Huaizhong Health Group Inc (ADAD) | $-19.47K | 0.00% | 0.00x | $3.15K |